GAMMA Investing’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101K Sell
4,871
-3,523
-42% -$77.9K ﹤0.01% 1797
2026
Q1
$196K Buy
8,394
+5,731
+215% +$179K 0.01% 1135
2025
Q4
$118K Sell
2,663
-1,487
-36% -$83.5K 0.01% 1459
2025
Q3
$304K Buy
4,150
+1,169
+39% +$76.2K 0.02% 713
2025
Q2
$183K Buy
2,981
+165
+6% +$9.21K 0.01% 973
2025
Q1
$163K Buy
2,816
+1,081
+62% +$68.3K 0.01% 886
2024
Q4
$92.6K Buy
1,735
+296
+21% +$14.5K 0.01% 1172
2024
Q3
$62.7K Buy
1,439
+412
+40% +$13.7K 0.01% 1324
2024
Q2
$28.7K Sell
1,027
-453
-31% -$11.9K ﹤0.01% 1612
2024
Q1
$39.8K Buy
1,480
+8
+0.5% +$228 0.01% 1188
2023
Q4
$39.7K Buy
+1,472
New +$34.8K 0.01% 1040

Other funds holding DOCS

GAMMA Investing's DOCS Position: Q2 2026 in Review

GAMMA Investing reduced its Doximity (DOCS) stake by 42% in Q2 2026, selling an estimated $77.9K and leaving 4,871 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #1797.

GAMMA Investing first reported a position in DOCS in Q4 2023 and has held it in 11 quarters since. The position peaked at $304K in Q3 2025. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • GAMMA Investing held 4,871 shares of Doximity worth $101K as of Q2 2026.
  • GAMMA Investing sold 3,523 Doximity shares in Q2 2026, an estimated $77.9K.
  • Doximity made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1797 holding.
  • GAMMA Investing first reported a position in Doximity in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Doximity position peaked at $304K in Q3 2025.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.